230 participants
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-28
- Start Date:
- 2024-03-21
- Completion:
- 2027-06-30
Conditions
- Multiple Myeloma
Interventions
- BIOLOGICAL
No Results Yet